Comparison of Human Cytochrome P450 Inhibition by the Thienopyridines Prasugrel, Clopidogrel, and Ticlopidine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Human Cytochrome P450 Inhibition by the Thienopyridines Prasugrel, Clopidogrel, and Ticlopidine

Published:2008 Issue:6 Volume:23 Page:412-420
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Hagihara Katsunobu,Nishiya Yumi,Kurihara Atsushi,Kazui Miho,Farid Nagy A.,Ikeda Toshihiko

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference34 articles.

1. ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction

2. Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes;Schulman;JAMA,2004

3. Pharmacology of CS-747 (Prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y(12) receptor antagonist activity;Niitsu;Semin. Thromb. Hemost.,2005

4. Clopidogrel and ticlopidine: P2Y(12) adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis;Savi;Semin. Thromb. Hemost.,2005

5. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments;Kam;Anaesthesia,2003

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism-based inactivation of cytochromes P450: implications in drug interactions and pharmacotherapy;Xenobiotica;2024-08-28

2. Early Preclinical Studies of Ergosterol Peroxide and Biological Evaluation of Its Derivatives;ACS Omega;2024-08-19

3. The effects of CYP2B6 inactivators on the metabolism of ciprofol;PLOS ONE;2024-07-29

4. Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapy;Chemico-Biological Interactions;2023-08

5. Decreased plasma exposure of clopidogrel active metabolite in rats after long‐term treatment with clopidogrel;Biopharmaceutics & Drug Disposition;2023-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3